For-Profit Medicine Incentivizes Overmedicating Our Elderly
From NBC: According to human rights investigators, anti-psychotic drugs are often administered to nursing home residents to address behavioral issues. Our nation's lack of funding...
8 Years of Mental Health Research Distilled to 4 Infographics
Pictures are worth a thousand words. So I’ve chosen pictures to distill the mountain of mental health research I’ve examined over the last eight years. Three infographics summarize research on psychiatric drugs, and one asserts why I think Integrative Mental Health is the best path available for mental health recovery.
Care Homes Over-Prescribing Drugs for Residents with Dementia
From The Guardian: According to a new Human Rights Watch report, U.S. nursing homes are inappropriately prescribing antipsychotics to an estimated 179,000 residents with dementia each...
Researchers Challenge Industry-Friendly Depression Guideline
Review of a new mixed depression guideline reveals financial bias of guideline developers and lack of evidence supporting recommendations for prescribing of antipsychotics.
Your Pills Are Spying On You
From Pacific Standard: The new Abilify MyCite pill, which contains a digital sensor that tracks whether a patient has ingested the drug, has the potential...
Vitamin B6 Effective in Reducing Antipsychotic Induced Akathisia
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.
Life Sentence: Life Behind the Bars of the Mental Health System
The minute you sit down in the chair in a mental health professional's office, you’re no longer seen as a person. The mental health system is incapable of seeing past the solid wall of your current label. Their only cure is drugs. "First Do No Harm" are powerful words. It’s unfortunate they don’t apply to psychiatry.
Mental Health Inc: A New Book by Art Levine
From AlterNet: A new book my Art Levine, Mental Health Inc: How Corruption, Lax Oversight and Failed Reforms Endanger Our Most Vulnerable Citizens, exposes the greed...
Psychiatry is a Disaster Area in Healthcare That Needs Attention
In this piece for The BMJ, Dr. Peter Gøtzsche points out several of the major problems with the drug-based paradigm of psychiatric care as well as...
Therapeutic Alliance: Implications for Practice and Policy
In this piece for Psychiatric Services, Dr. Sandra Steingard comments on the implications of a recent meta-analysis demonstrating the positive effects of the therapeutic alliance on pharmacologic...
Antipsychotics, Restraints, and Seclusion Raising Concerns
From ABC Australia: Australia's high rate of antipsychotic prescriptions, as well as the frequent usage of restraints and seclusion, has raised concerns among Australian mental health advocates, researchers,...
Reducing Antipsychotic Use May Improve Health for People with Mental Health Diagnoses
A new study offers radical solutions for improving the cardiovascular health of people with mental health diagnoses: reducing antipsychotic prescriptions..
Whistleblower Files Lawsuit Against AstraZeneca
From the Chicago Tribune: Former drug sales representative Allison Zayas became a whistleblower against her old company, AstraZeneca, after learning that a combination of Seroquel...
Anticholinergic Medications Linked to Dementia Similar to Early Alzheimer’s
A new study, published in the Journal of Clinical Psychiatry, investigates the effects of anticholinergic medications, such as antidepressants and antipsychotics, on cognition in older adults diagnosed with schizophrenia.
Exercise Intervention for Youth at Risk for Psychosis Shows Promise
A new pilot study finds that an exercise intervention can lead to improvement in clinical, social, and cognitive domains for those deemed at risk for psychosis.
The Other Big Drug Problem: Older People Taking Too Many Pills
From The Washington Post: In addition to the opioid crisis, America has one other prescription drug epidemic — older Americans are taking far too many unnecessary...
Mad Pride: Making a Truce With the Voices in Your Head
In this piece for Vice, Tess McClure describes New Zealand's Mad Pride movement, a movement that seeks to destigmatize, normalize, and celebrate experiences of voice-hearing...
Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression
The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.
Study Challenges Assumption that Schizophrenia Impairs Cognitive Ability
Secondary factors may impair performance on cognitive tasks, making it difficult for individuals diagnosed with schizophrenia to perform to the best of their ability.
Children Diagnosed with ADHD Younger are More Likely to get Multiple Medications
New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.
The Orwellian New Digital Abilify Will Subjugate Vulnerable People Across the US
The FDA approved the prescribing and sale of a new hi-tech compliance-monitoring “antipsychotic” drug this week. A new chapter in human darkness has descended — one that is applauded by the alliance of control addicts that made it happen.
Patients on Antipsychotics at High Risk for Cardiovascular Issues, Study Finds
Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.
The Issue of Over-Diagnosing in Psychiatry
From The Concordian: On October 30th, Dr. Joel Paris, a professor of psychiatry at McGill University, gave a lecture about the dangers and consequences of...
FDA Approves Pill That Digitally Tracks if Patients Have Ingested it
The FDA has approved Abilify MyCite, a pill with a sensor that digitally tracks whether patients have taken their medication.
"The system works by sending...
Outcome Reporting Bias in Antipsychotic Medication Trials
A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
